METHOTREXATE TOXICITY PRECIPITATED BY AZAPROPAZONE

被引：34

作者：

DALY, HM

SCOTT, GL

BOYLE, J

ROBERTS, CJC

机构：

[1] BRISTOL ROYAL INFIRM,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND

[2] BRISTOL ROYAL INFIRM,DEPT HAEMATOL,BRISTOL BS2 8HW,AVON,ENGLAND

[3] BRISTOL ROYAL INFIRM,DEPT DERMATOL,BRISTOL BS2 8HW,AVON,ENGLAND

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1986年 / 114卷 / 06期

关键词：

D O I：

10.1111/j.1365-2133.1986.tb04883.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：733 / 735

页数：3

共 17 条

[1]

Adams J D, 1976, Australas J Dermatol, V17, P39, DOI 10.1111/j.1440-0960.1976.tb00587.x

[2] PROLONGATION AND ENHANCEMENT OF SERUM METHOTREXATE CONCENTRATIONS BY PROBENECID [J].

AHERNE, GW ;

PIALL, E ;

MARKS, V ;

MOULD, G ;

WHITE, WF .

BRITISH MEDICAL JOURNAL, 1978, 1 (6120) :1097-1099

[3] HYPOGLYCEMIA INDUCED BY AZAPROPAZONE-TOLBUTAMIDE INTERACTION [J].

ANDREASEN, PB ;

SIMONSEN, K ;

BROCKS, K ;

DIMO, B ;

BOUCHELOUCHE, P .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (04) :581-583

[4] METHOTREXATE - CLINICAL PHARMACOLOGY, CURRENT STATUS AND THERAPEUTIC GUIDELINES [J].

BLEYER, WA .

CANCER TREATMENT REVIEWS, 1977, 4 (02) :87-101

[5]

FEHSKE KJ, 1980, ARCH PHARM, V313, P115

[6] INTERACTION OF AZAPROPAZONE WITH PHENYTOIN [J].

GEANEY, DP ;

CARVER, JG ;

ARONSON, JK ;

WARLOW, CP .

BRITISH MEDICAL JOURNAL, 1982, 284 (6326) :1373-1373

[7] PHARMACOKINETIC INVESTIGATION OF THE INTERACTION OF AZAPROPAZONE WITH PHENYTOIN [J].

GEANEY, DP ;

CARVER, JG ;

DAVIES, CL ;

ARONSON, JK .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) :727-734

[8]

HART FD, 1978, EUR J RHEUMATOL INFL, V1, P142

[9]

Jones C J, 1976, Curr Med Res Opin, V4, P3, DOI 10.1185/03007997609109277

[10]

LIEGLER DG, 1969, CLIN PHARMACOL THER, V10, P849

← 1 2 →